Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
-
“Global WiFi” Surpasses 24 Million Users & Celebrates 9 Consecutive Years as Japan’s No. 1
-
Renewal Fuels, Inc. (OTC: RNWF), Operating as American Fusion, Appoints Michael G. Smith as Chief Legal Officer and Director and Files New Federal Trademark Applications with the USPTO
-
Skyline Bankshares, Inc. Announces Fourth Quarter 2025 Results
-
Pan American Energy Selects Key Contractors to Support Planned Winter Drill Program at the Tharsis Project, Northwest Territories
-
Maxus Mining Appoints Morgan Verge as Vice President of Exploration
-
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
-
Enphase Energy Demonstrates Global IQ Bidirectional EV Charging Platform, Targeting Volume Production in Q4 2026
-
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
-
Red Cat Secures New Orders for Black Widow™ Drones from Asia-Pacific Ally
-
Enlight Reaches Final Development Milestones for CO Bar, Its Largest Project to Date
-
SunPower Secures $20 Million SEPA Agreement
-
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease
-
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
-
Bitcoin Volatility Highlights Alternative Infrastructure Participation Models Such as Bitcoin Everlight
-
Denali Therapeutics To Host Webcast Highlighting Presentations on Enzyme TransportVehicle™ Programs at the 2026 WORLDSymposium™
-
Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® (roflumilast) Cream 0.05% in Infants with Mild to Moderate Atopic Dermatitis
-
Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
-
Smithsonian Journeys Announces New Trips for 2027
-
Avaap Named Snowflake Premier Partner
-
Deep Isolation Launches Full-Scale Demonstration Program for Nuclear Waste Disposal
-
Ridgeline Introduces Intelligent Operations to Power a New Operating Model for Investment Management
-
SPS Commerce Announces Date of Fourth Quarter and Fiscal Year 2025 Financial Results
-
Apollo to Present at the UBS Financial Services Conference
-
Living in California Releases 2026 Guide to Living in Los Angeles, a practical, data-informed resource designed to help future residents understand the realities of life in LA
-
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
-
Flock Safety Engages Bishop Fox to Set the Industry Standard in Cybersecurity for its Public Safety Platform
-
Aqua Metals to Participate in NAATBatt 2026 Annual Meeting in Tucson; Discuss Commercial and Technical Milestones in Domestic Battery Materials
-
Kaltura Recognized as a Notable Vendor in Virtual Event Management Platforms Landscape Report by the Leading Analyst Firm
-
Dave Cantin Group Releases 2026 Automotive Market Outlook Report Ahead of NADA
-
“Global WiFi” Surpasses 24 Million Users & Celebrates 9 Consecutive Years as Japan’s No. 1
-
eToro Deepens Its Connection With Retail Investors Through New Shareholder Engagement Initiative in Partnership with Stockperks
-
AirJoule Technologies to Partner with TenX Investment for Exclusive Middle East Distribution of AirJoule™ Solutions
-
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
-
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
-
FintechVendors.com (FVC) Expands with Launch of ‘FVC News Center’ Newsletter and ‘FVC News Minute’ Video Series
-
ASML reports transactions under its current share buyback program
-
MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day
-
Smartkem Signs Letter of Intent with Carbonium Core, Inc. to Expand Advanced Materials Portfolio into Nuclear-Grade Graphite
-
Schouw & Co. share buy-back programme, week 5 2026
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PERSONAL FINAN - Ordinary Shares
-
$ARTX Makes a Major Dual-Exchange Debut, Ultiland Demonstrates Strong Ecosystem Progress with a Three-Layer Strategy to Reinforce Its Value Flywheel
-
Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.085 per Share for February 2026
-
Unipart launches new online store
-
Terms for Nykredit's and Totalkredit's auctions - Totalkredit A/S
-
Fusemachines and IBM Platinum Partner ModulAIre Announce Strategic Partnership to Deliver Enterprise AI Solutions Powered by Fusemachines AI Studio
-
Hain Celestial to Sharpen Strategic Focus; Enters Into Agreement to Sell North America Snacks Business
-
Terms for Nykredit's and Totalkredit's auctions - Nykredit Realkredit A/S
-
Net Asset Value
-
Nivex CEO Simon Hardy Unveils NXB Mechanism and Quant-Mind Global Partner Program to Build a Long-Term Ecosystem
